Myriad Genetics (MYGN) Rides High: Exploring The Surging Stock Momentum
In the wake of a robust financial report, Myriad Genetics, Inc. (NASDAQ: MYGN) is currently experiencing an upward trajectory in its stock performance on the US stock market. As of the last check during current-market session, MYGN shares have surged by 18.30%, reaching $23.40. Strong Financial Performance In Q1 2024 Myriad Genetics (MYGN) commenced 2024 […]
Myriad Genetics (MYGN) Rides High: Exploring The Surging Stock Momentum Read More »